Clinical Trial Update: Fruquintinib Combined With PD-1 Inhibitor as First-line Maintenance Therapy for Advanced Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating fruquintinib in combination with a PD-1 inhibitor as first-line maintenance therapy for advanced gastric cancer and gastroesopha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Adenocarcinoma
• Gastroesophageal Junction Adenocarcinoma

Drugs mentioned

• Fruquintinib (fruquintinib)
• PD-1 inhibitor

Snippet

Sponsor: Ruijin Hospital | Conditions: Gastric Adenocarcinoma, GEJ Adenocarcinoma | Phase 2 | Status: NOT_YET_RECRUITING